Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2024-10-28 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2024年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "华邦生命健康股份有限公司2024 年第三季度报告" which translates to "Huabang Life Health Co., Ltd. 2024 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the third quarter of 2024. The document explicitly states it is a quarterly report and mentions it is unaudited. The length is substantial (15,000 characters), and it contains actual financial statements and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-10-28 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 20th meeting of the 8th Board of Directors of Huabang Life Health Co., Ltd. It includes details about the meeting date, attendance, and voting results. The key point is the approval of the 2024 third quarter report, but the actual report is not included here; instead, it references that the report is published separately on official platforms. The document also mentions the approval of a new internal policy (舆情管理制度). The document length is short (835 characters), and it serves as a notice of board meeting resolutions rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting decisions and approvals, including the approval of a quarterly report, but does not contain the report itself.
2024-10-28 Chinese
舆情管理制度(2024年10月)
Governance Information Classification · 95% confidence The document is titled '舆情管理制度' which translates to 'Public Opinion Management System' or 'Crisis Management Policy' for the company 华邦生命健康股份有限公司. It outlines the company's internal policies and procedures for managing public opinion, media reports, and potential negative information affecting the company. It includes organizational structure, responsibilities, principles for handling information, reporting processes, and legal responsibilities. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no management changes, no capital updates, no earnings information, no legal proceedings updates, and no investor presentations. The document is a governance or internal policy document related to information disclosure and crisis management. This fits best under Governance Information (CGR) which covers reports detailing the company's internal rules, board structure, and governance practices. The document is not an announcement or a short notice, but a full policy document. Therefore, the classification is CGR with high confidence.
2024-10-28 Chinese
关于实际控制人部分股份质押的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the pledge of shares by the actual controller of the company, Zhang Songshan. It details the number of shares pledged, the proportion of shares pledged relative to total holdings and company shares, the pledge period, and the purpose of the pledge. It also includes cumulative pledge information and clarifies that the pledge is not related to the company's operational needs. The document is a regulatory disclosure about share pledging by a major shareholder, which fits the category of a Major Shareholding Notification. It is not a financial report, earnings release, or management report, nor is it an announcement of a meeting or voting results. The document length is about 2051 characters, which is short and focused on share pledge details. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2024-10-25 Chinese
关于科稷达隆获得农业转基因生物安全证书的自愿性信息披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary information disclosure announcement by Huabang Life Health Co., Ltd. regarding its subsidiary obtaining an agricultural genetically modified organism (GMO) safety certificate. It includes details about the certificate, the project, and risk warnings. The document is short (1078 characters) and serves as an announcement of a regulatory approval rather than a financial report or detailed management information. It does not contain financial data, management changes, or voting results. It is not a report but an announcement of a regulatory event related to the company's operations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-14 Chinese
2024030：关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, compliance with regulations, and future intentions to continue the buyback. It does not contain financial statements or earnings data, nor is it a full report or presentation. The content matches the description of a Transaction in Own Shares (POS) filing, which reports on share buybacks or sales by the company.
2024-10-08 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.